Regeneron Pharmaceuticals names three winners of its Regeneron Prize for Creative Innovation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

REGENERON PHARMACEUTICALS Inc. announced three of the winners of the fourth annual Regeneron Prize for Creative Innovation, an award designed to acknowledge, reward and foster talented early-career biomedical scientists. Altogether, Regeneron will award $155,000 in prize money to 10 awardees and two institutions. Two winners of the Regeneron Prize will each receive a $50,000 cash...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login